![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Transplant Product Shown to Predict Oral Mucositis with a High Degree of Accuracy in Patients Undergoing Conditioning Regimens Prior to Hematopoetic Stem Cell Transplant
11 déc. 2012 08h00 HE
|
Inform Genomics
Boston, MA, Dec. 11, 2012 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Presents Results For OnPART(tm) Showing High Degree Of Accuracy Predicting Six Common Side Effects Of Dose Dense Chemotherapy
06 déc. 2012 09h50 HE
|
Inform Genomics
Boston, MA, Dec. 6, 2012 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Announces Positive Top-Line Results in First Phase of Development for OnPART(TM) Personalized Medicine Product
01 oct. 2012 08h00 HE
|
Inform Genomics
Boston, MA, Oct. 1, 2012 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a private company focused on developing
novel platforms of genomic-based personalized medicine products for
cancer supportive care...